ReviewFrontiers in microbiology2016
Biodegradation of Mycotoxins: Tales from Known and Unexplored Worlds.
Review in Frontiers in microbiology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 76 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
76 citing papers in PubMed, 187 citations in OpenAlex.
- Isolation and Characterization of Sphingopyxis sp. Q841: A New Zearalenone- Degrading Strain.Current microbiology · 2026Article
- In Vitro Reduction of Extractable Zearalenone and Screening of Tentative Transformation Products byToxins · 2026Article
- The effect of biological control on mycotoxin concentrations and the mycobiome in durum wheat grain and stems.Scientific reports · 2026Article
- Contribution of terrestrial processes in reducing environmental mycotoxin levels: a review on mycotoxin-soil interactions.Mycotoxin research · 2026Review
- Microbiome-mycotoxin interactions and probiotic strategies: implications for gut health and cancer.Frontiers in nutrition · 2026Review
- Article
- Green Solutions for Food Safety: The Emerging Applications of Zearalenone-Degrading Enzymes.Foods (Basel, Switzerland) · 2025Review
- Review
- Unlocking the Potential ofFoods (Basel, Switzerland) · 2025Article
- Article
- Starch can expedite the screening for bacterial aflatoxin degraders.Scientific reports · 2024Article
- Mycotoxin Biodegradation byToxins · 2024Review
- Mutual interaction of the entomopathogenic and endophytic fungus Metarhizium anisopliae with zearalenone as a native component of crude Fusarium extract.Scientific reports · 2024Article
- Article
- Enzymatic Degradation of Deoxynivalenol with the Engineered Detoxification Enzyme Fhb7.JACS Au · 2024Article
- Trichothecenes and Fumonisins: Key Players inToxins · 2024Review
- Detoxification of aflatoxin B1 by aFrontiers in microbiology · 2024Article
- Effect of Mycotoxins in Silage on Biogas Production.Bioengineering (Basel, Switzerland) · 2023Article
- SoilJournal of fungi (Basel, Switzerland) · 2023Review
- Novel Strategies for the Biodegradation and Detoxification of Mycotoxins in Post-Harvest Grain.Toxins · 2023Article
16 more citing papers are in PubMed but not listed here.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Exposure to mycotoxins, secondary metabolites produced by fungi, may infer serious risks for animal and human health and lead to economic losses. Several approaches to reduce these mycotoxins have been investigated such as chemical removal, physical binding, or microbial degradation. This review focuses on the microbial degradation or transformation of mycotoxins, with specific attention to the actual detoxification mechanisms of the mother compound. Furthermore, based on the similarities in chemical structure between groups of mycotoxins and environmentally recalcitrant compounds, known biodegradation pathways and degrading organisms which hold promise for the degradation of mycotoxins are presented.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.